Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi

suck pdf from helios


suck pdf from google scholar
unlimited free pdf from europmc32282986    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32282986  :  Publisher
PDF vom PMID32282986

suck abstract from ncbi

Nephropedia Template TP Text

Twit Text FOAVip

Twit Text #

English Wikipedia

  • Clinical characteristics and immunosuppressant management of coronavirus disease 2019 in solid organ transplant recipients #MMPMID32282986
  • Zhong Z; Zhang Q; Xia H; Wang A; Liang W; Zhou W; Zhou L; Liu X; Rao L; Li Z; Peng Z; Mo P; Xiong Y; Ye S; Wang Y; Ye Q
  • Am J Transplant 2020[Jul]; 20 (7): 1916-1921 PMID32282986show ga
  • Over 1 000 000 cases of coronavirus disease 2019 (COVID-19) have been confirmed since the worldwide outbreak began. Not enough data on infected solid organ transplant (SOT) recipients are available, especially data about the management of immunosuppressants. We report two cases of COVID-19 in two transplant recipients, with different treatments and prognoses. The first patient received liver transplantation due to hepatitis B virus-related hepatocellular carcinoma and was confirmed to have COVID-19 9 days later. Following a treatment regimen consisting of discontinued immunosuppressant use and low-dose methylprednisolone-based therapy, the patient developed acute rejection but eventually recovered. The other patient had undergone a renal transplant from a living-related donor 17 years ago, and was admitted to the hospital because of persistent fever. This patient was also diagnosed with COVID-19. His treatment regimen consisted of reduced immunosuppressant use. No signs of rejection were observed during the regimen. In the end, the patient successfully recovered from COVID-19. These effectively treated cases can provide a basis for immunosuppressant management of COVID-19-positive SOT recipients.
  • |*Organ Transplantation[MESH]
  • |*Transplant Recipients[MESH]
  • |Adult[MESH]
  • |Betacoronavirus[MESH]
  • |COVID-19[MESH]
  • |Carcinoma, Hepatocellular/complications/surgery[MESH]
  • |Coronavirus Infections/*complications/*therapy[MESH]
  • |Hepatitis B virus[MESH]
  • |Hepatitis B/complications/surgery[MESH]
  • |Humans[MESH]
  • |Immunosuppressive Agents/*therapeutic use[MESH]
  • |Kidney Failure, Chronic/complications/surgery[MESH]
  • |Kidney Transplantation[MESH]
  • |Liver Neoplasms/complications/surgery[MESH]
  • |Liver Transplantation[MESH]
  • |Male[MESH]
  • |Methylprednisolone/administration & dosage[MESH]
  • |Middle Aged[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/*complications/*therapy[MESH]
  • |Prognosis[MESH]
  • |SARS-CoV-2[MESH]
  • |Treatment Outcome[MESH]

  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    1916 7.20 2020